Page last updated: 2024-08-22

galactosamine and remimazolam

galactosamine has been researched along with remimazolam in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
An, S; Chen, Z; Fang, H; Huang, Q; Li, L; Wang, J; Wu, J; Yang, H; Zeng, Z; Zhang, Y	1

Other Studies

1 other study(ies) available for galactosamine and remimazolam

Article	Year
Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages. International immunopharmacology, 2021, Volume: 101, Issue:Pt B Topics: Animals; Benzodiazepines; Chemical and Drug Induced Liver Injury; Cytokines; Galactosamine; Inflammation; Lipopolysaccharides; Liver; Macrophages; Male; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; RAW 264.7 Cells; Receptors, GABA-A; Sepsis	2021

Article

Year

Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages.

International immunopharmacology, 2021, Volume: 101, Issue:Pt B

Topics: Animals; Benzodiazepines; Chemical and Drug Induced Liver Injury; Cytokines; Galactosamine; Inflammation; Lipopolysaccharides; Liver; Macrophages; Male; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; RAW 264.7 Cells; Receptors, GABA-A; Sepsis

2021